SAN DIEGO--(BUSINESS WIRE)--Auxilium Biotechnologies, a leader in regenerative medicine, is pleased to announce the enrollment of the first patient in its clinical trial evaluating the safety and ...
Damage to the optic nerve can lead to irreversible blindness. A newly investigated regeneration factor could change that, UConn researchers report in the May 2024 issue of Experimental Neurology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback